NEW YORK, March 14, 2012 (GLOBE NEWSWIRE) -- Dow Jones Indexes, a leading global index provider, today announced the launch of the Dow Jones Pring U.S. Business Cycle Index, a gauge designed in collaboration with Pring Research to reflect its proprietary investment strategy that tactically allocates among stock, bond, commodity and cash segments based on the phase of the economic business cycle.
The index will closely track the investment strategy developed by Pring Research's Principal and President, Martin J. Pring, an award-winning author who has devised a rules-based methodology with the goal of achieving higher risk-adjusted returns relative to multi-asset or "blended" benchmarks.
"In building this new index with Pring Research's proprietary investment strategy at its core, we have created a unique tool for measuring an investment strategy that dynamically changes the mix of several asset classes depending on the current stage of the U.S. economic business cycle," said Dow Jones Indexes' President, http://press.djindexes.com/index.php/bios/">Michael A. Petronella.
Backtested historical data calculated daily back to June 30, 2006 indicate the Dow Jones Pring U.S. Business Cycle Index has outperformed equities, commodities, and multi-asset benchmarks on an absolute and risk-adjusted basis. Dynamic in nature, the index automatically rebalances on a monthly basis in response to signals generated by the model.
Mr. Pring founded Sarasota, Fla.-based Pring Research in 1981 and began providing research for financial institutions and individual investors around the world. Since 1984, he has published the Intermarket Review, a monthly market report offering long-term synopses of the world's major financial markets. Mr. Pring is also chairman of Pring Turner Capital Group – a Walnut Creek, Calif.-based money management firm dedicated to allocating assets according to Mr. Pring's proprietary U.S. business-cycle research.
Over the course of his career, Mr. Pring has been quoted in many major financial publications and has written more than 20 books, including Technical Analysis Explained, which has been translated into 10 languages and is required reading for the Chartered Market Technician's exam.
Today's index launch follows the September 2011 announcement by Dow Jones Indexes and Pring Research in which the firms announced an agreement to develop and co-brand a U.S. business cycle gauge designed to closely track Pring Research's proprietary investment strategy.
Journalists may e-mail questions regarding this press release to media@djindexes.com.
About Dow Jones Indexes
Dow Jones Indexes (www.djindexes.com) is a leading full-service index provider that develops, maintains and licenses indexes for use as benchmarks and as the basis of investment products. Best-known for the Dow Jones Industrial Average, Dow Jones Indexes offers more than 130,000 equity indexes as well as fixed-income and alternative indexes, including measures of hedge funds, commodities and real estate. Dow Jones Indexes employs clear, unbiased and systematic methodologies that are fully integrated within index families. Dow Jones Indexes is part of a joint venture company owned 90 percent by CME Group Inc. (www.cmegroup.com) and 10 percent by Dow Jones & Company, Inc. (www.dowjones.com), a News Corporation company (Nasdaq:NWS) (Nasdaq:NWSA) (ASX:NWS) (ASX:NWSLV) (www.newscorp.com). "Dow Jones Indexes" is a service mark of Dow Jones Trademark Holdings LLC and has been licensed for use by CME Group Index Services LLC.
The Dow Jones Indexes logo is available at http://www.globenewswire.com/newsroom/prs/?pkgid=1289
Real and historical index data is available for the index. All estimated daily historical closing prices prior to the initial publication date of the index are based on back-testing (i.e., calculations of how the index might have performed in the past if it had existed). Back-tested performance information is purely hypothetical and is solely for informational purposes. Back-tested performance does not represent actual performance, and past performance is not indicative of future results.